ArticlePharmaceuticals (Basel, Switzerland)2025

Real-World Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Older Adults with Type 2 Diabetes and Cardiometabolic Disease.

Ibrahim S Alhomoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.